Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editor's notes
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI119126

Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.

T Matsuoka, Y Kajimoto, H Watada, H Kaneto, M Kishimoto, Y Umayahara, Y Fujitani, T Kamada, R Kawamori, and Y Yamasaki

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Matsuoka, T. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Kajimoto, Y. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Watada, H. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Kaneto, H. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Kishimoto, M. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Umayahara, Y. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Fujitani, Y. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Kamada, T. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Kawamori, R. in: JCI | PubMed | Google Scholar

First Department of Medicine, Osaka University School of Medicine, Tokyo, Japan.

Find articles by Yamasaki, Y. in: JCI | PubMed | Google Scholar

Published January 1, 1997 - More info

Published in Volume 99, Issue 1 on January 1, 1997
J Clin Invest. 1997;99(1):144–150. https://doi.org/10.1172/JCI119126.
© 1997 The American Society for Clinical Investigation
Published January 1, 1997 - Version history
View PDF
Abstract

Prolonged poor glycemic control in non-insulin-dependent diabetes mellitus patients often leads to a decline in insulin secretion from pancreatic beta cells, accompanied by a decrease in the insulin content of the cells. As a step toward elucidating the pathophysiological background of the so-called glucose toxicity to pancreatic beta cells, we induced glycation in HIT-T15 cells using a sugar with strong deoxidizing activity, D-ribose, and examined the effects on insulin gene transcription. The results of reporter gene analyses revealed that the insulin gene promoter is more sensitive to glycation than the control beta-actin gene promoter; approximately 50 and 80% of the insulin gene promoter activity was lost when the cells were kept for 3 d in the presence of 40 and 60 mM D-ribose, respectively. In agreement with this, decrease in the insulin mRNA and insulin content was observed in the glycation-induced cells. Also, gel mobility shift analyses using specific antiserum revealed decrease in the DNA-binding activity of an insulin gene transcription factor, PDX-1/IPF1/STF-1. These effects of D-ribose seemed almost irreversible but could be prevented by addition of 1 mM aminoguanidine or 10 mM N-acetylcysteine, thus suggesting that glycation and reactive oxygen species, generated through the glycation reaction, serve as mediators of the phenomena. These observations suggest that protein glycation in pancreatic beta cells, which occurs in vivo under chronic hyperglycemia, suppresses insulin gene transcription and thus can explain part of the beta cell glucose toxicity.

Version history
  • Version 1 (January 1, 1997): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts